These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15912646)

  • 1. [Cyclosporine dose monitorization in renal transplantation C2 vs C0].
    Marcén R; Villafruela JJ
    Nefrologia; 2005; 25(2):106-12. PubMed ID: 15912646
    [No Abstract]   [Full Text] [Related]  

  • 2. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
    Kyllönen LE; Salmela KT
    Transplantation; 2006 Apr; 81(7):1010-5. PubMed ID: 16612277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
    Higgins RM; Kanji H; Hernon M; Harrison P; Lam FT; Kashi SH
    Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C0 vs C2 levels and their implications in kidney transplantation].
    Cuero C; Delgado E; de González M; Medina C; Vernaza A; Moscoso J
    Rev Med Panama; 2002; 27():30-3. PubMed ID: 16737196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
    Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S; Vareesangthip K; Ong-ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey to determine the blood concentration of cyclosporine 2 hours postdose in stable renal transplant patients.
    Jorga A; Holt DW; Yaqoob M; Whittaker C; Johnston A
    Transplant Proc; 2004 Dec; 36(10):3239-41. PubMed ID: 15686737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
    Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
    Büchler M; Chadban S; Cole E; Midtvedt K; Thervet E; Prestele H; Keown P
    Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is C0 better than C2 as a determinant of rejection in renal transplant recipients?
    Midtvedt K
    Kidney Int; 2004 Aug; 66(2):869. PubMed ID: 15253751
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
    Mathias HC; Ozalp F; Will MB; Borland W; Payne C; Kerr M; Lockhart J; Murday AJ
    J Heart Lung Transplant; 2005 Dec; 24(12):2137-43. PubMed ID: 16364862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [News from transplantation medicine. Less rejection thanks to new monitoring].
    MMW Fortschr Med; 2000 Nov; 142(44):54. PubMed ID: 11107813
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine trough level or 2-hour postdose level monitoring among kidney transplant recipients: Iranian practice.
    Einollahi B; Rostami Z; Teimoori M
    Iran J Kidney Dis; 2012 Sep; 6(5):389-90. PubMed ID: 22976267
    [No Abstract]   [Full Text] [Related]  

  • 17. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F
    J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
    Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoral C2 monitoring in maintenance liver transplant patients: a step forward?
    Levy GA; Cole EH
    Liver Transpl; 2004 Feb; 10(2):190-2. PubMed ID: 14762855
    [No Abstract]   [Full Text] [Related]  

  • 20. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.